Erudio Healtherudio.com
Clinical trial · no report yet · Phase 3
PRODIGE 7
Systemic Chemotherapy With or Without Intraperitoneal Chemohyperthermia in Treating Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer
- NCT00769405 ↗
- Completed
- UNICANCER
- Deep
We haven't built an HCP commentary report on PRODIGE 7 (oxaliplatin in colorectal peritoneal metastases) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on PRODIGE 7 so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 21 | |
| Podcasts | 1 |
The trial
ClinicalTrials.gov- Official title
- Phase III Study Evaluating the Use of Systemic Chemotherapy and Chemohyperthemia Intraperitoneal Preoperatively (CHIP) and After Maximum Resection of Peritoneal Carcinomatosis Originating With Colorectal Cancer
- Phase
- Phase 3
- Status
- Completed
- Conditions
- Colorectal Cancer; Primary Peritoneal Cavity Cancer
- Interventions
- fluorouracil; leucovorin calcium; oxaliplatin; hyperthermia treatment
- Arms
- Arm I · Experimental
- Arm II · Experimental
- Enrollment
- 264
- Primary outcomes
- Overall survival
- Sponsor
- UNICANCER
- Start
- Feb 2008
- Primary completion
- Dec 2015
- Results posted
- No
- Registry record
- NCT00769405 · updated Aug 30, 2016
Publications
linked from the registry- Quenet F, Elias D, Roca L, Goere D, Ghouti L, Pocard M, Facy O, Arvieux C, Lorimier G, Pezet D, Marchal F, Loi V, Meeus P, Juzyna B, de Forges H, Paineau J, Glehen O; UNICANCER-GI Group and BIG Renape Group. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021 Feb;22(2):256-266. doi: 10.1016/S1470-2045(20)30599-4. Epub 2021 Jan 18. PubMed 33476595